Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Allarity Therapeutics, Inc. on Post-Effective Amendment No. 1 to Form S-1 (File No. 333-259484) of our report dated May 16, 2022, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the consolidated financial statements of Allarity Therapeutics, Inc. as of December 31, 2021 and for the year then ended which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum llp
Marcum llp
Philadelphia, PA
June 1, 2022
